MetaBase
Human-curated high confidence biological knowledge to accelerate causal, mechanism driven drug discovery
Turning curated biological knowledge into therapeutic insight
Biopharma R&D teams face a growing challenge: turning vast, fragmented omics data and rapidly expanding scientific literature into clear, reliable, and actionable insights. Disconnected data sources and inconsistent curation slow discovery and erode confidence in decision-making—underscoring the need for a trusted, integrated data foundation.
MetaBase is a premium, expert-curated biological knowledgebase that helps understand disease biology and molecular mechanisms and supports hypothesis generation for biomarkers and targets. It accelerates drug discovery and translational research through high quality systems biology intelligence and data-driven decision making.
Model and understand disease pathways
Understand and visualize biological relationships
Identify and validate targets and biomarkers
Access critical data through flexible delivery options tailored to your organization’s needs.
Flexible, enterprise-ready access & integration
Access data via R and SQL, enabling efficient use and seamless integration into bioinformatics pipelines, omics workflows, AI platforms, and large scale analytics systems in pharma and biotech.
Comprehensive biological knowledge in one integrated resource
Unifies genetic, epigenetic, tissue specific, and multi species biological data into a single, harmonized knowledgebase to enable consistent and reproducible biological interpretation.
The foundation of Clarivate's R&D Knowledge Graph
MetaBase content is fully integrated into R&D Knowledge Graph from Clarivate, extending its value beyond a standalone database into a connected, graph based discovery platform.
Powering Cortellis Pathfinder
Cortellis Pathfinder leverages MetaBase's high-quality content to empower researchers' analytical capabilities without the need to write code.
Advanced systems biology methods for data driven discovery
MetaBase is a trusted, mechanism-driven knowledge foundation powering next generation drug discovery.
Accelerate innovation in pharma and biotech
Combines scientific rigor and mechanistic insight at scale to reduce early discovery uncertainty and help organizations interpret data, understand disease biology, and make faster R&D decisions.
Built for causal biology and mechanism of action reconstruction
Captures how molecular entities interact, why interactions occur, and how reliable the evidence is, enabling causal analysis, effect tracing, and confident omics interpretation
From pathways to targets: enabling discovery decisions
Links pathway‑level signals to therapeutic opportunities by highlighting relevant targets, supporting data‑driven prioritization, biomarker validation, and mechanistically grounded hypotheses.
Unmatched scale and continuous growth
MetaBase continues to expand rapidly, ensuring researchers work with current, comprehensive biological context. It contains more manually curated molecular interactions than all publicly available databases combined.
5.6 m+
1,6k+
5.3k+
329k+
684k+
59k+
5.6k+
279k+
Selected use cases showcasing the impact of MetaBase in real world research
Discover how MetaBase empowers researchers to translate data into actionable insight and confident decision-making
Explore our latest insights into thought leadership
Featuring webinars, publications and blog posts on key topics and cutting-edge research in the field
Machine learning combining multi-omics data and network algorithms identifies adrenocortical carcinoma prognostic biomarkers
MetaBase curated biological networks were used to integrate multi omics data with machine learning and network algorithms, enabling biologically interpretable prognostic biomarker discovery.
FAQS
MetaBase helps clinical researchers interpret complex transcriptomic and proteomic data in a high confidence biological and mechanistic context. By revealing causal pathways and mechanisms of action, it supports critical go/no go decisions on which drug candidates to advance through the development lifecycle. This reduces risk and saves time and cost by minimizing effort spent on biologically unsupported or unsuccessful research.
Yes. Expert‑curated MetaBase data have been used and cited in numerous peer‑reviewed publications that demonstrate the value of MetaBase in supporting causal analysis, biological interpretation of complex datasets, and mechanism‑of‑action and translational research, including Baker et al. 2024, Hosseini-Gerami et al. 2023, Costa Sa et al. 2019 and Hill et al. 2019
Organism-specific as well as experimental method-depending confidence levels are assigned to all molecular interactions upon revision of scientific literature along with reporting evidence.
MetaBase can be queried via a GUI, direct SQL access or through our custom MetaBaseR library, which provides integrated knowledge retrieval as well as advanced network biology analyses. In addition, a Python library is currently being developed.
MetaBase focuses on mechanistic depth, causality, and expert curation, rather than broad but shallow aggregation. While many resources catalog associations (e.g., gene–disease or protein–protein links), MetaBase captures directionality, effect, and biological context, enabling researchers to reason about cause‑and‑effect in biological systems.
It is also manually curated, ensuring high confidence and consistency across pathways, interactions, and annotations. This contrasts with databases that rely heavily on automated text mining or heterogeneous community submissions, which can introduce noise and ambiguity.
Finally, MetaBase is designed to support translational and clinical decision‑making, not just discovery. Its emphasis on curated pathways, causal networks, and mechanistic evidence makes it particularly valuable for interpreting omics data, understanding mechanisms of action, identifying actionable biomarkers, and making informed go/no‑go decisions in drug development.
